• Products
    • CE Approved Products
    • FDA Approved Products
    • NMPA Approved Products
  • Healthcare Specialists
    • Simplify the Complex
    • Clinical Trials
    • Events
  • Patient Education
    • Coronary Artery Disease
    • Coronary Stent Selection
    • Coronary Treatments
    • Peripheral Artery Disease
    • Peripheral Treatments
    • Awareness after Treatment
    • Q&A
  • About Us
    • Our Vision and Mission
    • History / Milestones
    • Leadership
    • Worldwide Locations
    • Compliance
  • Investor Relations
    • Announcements and circulars
    • Prospectus
    • Corporate Governance
      • Memorandum and Articles of Association
      • Board of Directors
      • Audit Committee
      • Remuneration Committee
      • Nomintation Committee
    • Listing documents
  • Media
    • Press Releases
    • News Coverage
  • Contact us
    • Enquiry
    • Careers
  • Language
    • 简体
    • 繁體
  • REGION
    • Global
    • Japan Japan
LANG
  • EN
  • 简
  • 繁
  • About Us
    • Our Vision and Mission
    • History / Milestones
    • Leadership
    • Worldwide Locations
    • Compliance
  • Investor Relations
    • Announcements and circulars
    • Prospectus
    • Corporate governance
      • Memorandum and Articles of Association
      • Board of Directors
      • Audit Committee
      • Remuneration Committee
      • Nomintation Committee
    • Listing documents
    • Corporate factsheet
  • Media
    • Press Releases
    • News Coverage
  • Contact us
    • Enquiry
    • Careers
OrbusNeich
  • Products
    • CE Approved Products
    • FDA Approved Products
    • NMPA Approved Products
  • Healthcare Specialists
    • Simplify the Complex
    • Clinical Trials
    • Events
  • Patient Education
    • Coronary Artery Disease
    • Coronary Stent Selection
    • Coronary Treatments
    • Peripheral Artery Disease
    • Peripheral Treatments
    • Awareness after Treatment
    • Q&A
Home » Investor Relations » Announcements and circulars

Announcements and circulars

May 2, 2025

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025

View

April 16, 2025

Notification Letter to Registered Shareholders – Notice of Publication of 2024 Annual Report, Circular including Notice of Annual General Meeting and Proxy Form and Environmental, Social and Governance Report 2024

View

April 16, 2025

Form of Proxy for use at the Annual General Meeting to be held on May 27, 2025

View

April 16, 2025

Notice of Annual General Meeting

View

April 16, 2025

(1) Proposed Re-election of Retiring Directors, (2) Proposed Grant of General Mandates to Issue Shares and to Repurchase Shares, (3) Re-appointment of Auditor, (4) Declaration and Payment of the Final Dividend out of the Share Premium Account and (5) Notice of Annual General Meeting

View

April 16, 2025

Environmental, Social and Governance Report 2024

View

April 16, 2025

Annual Report 2024

View

April 2, 2025

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025

View

March 7, 2025

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

View

March 7, 2025

Final Dividend for the Year Ended December 31, 2024

View

March 7, 2025

ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2024 AND RESIGNATION OF NON-EXECUTIVE DIRECTOR

View

March 3, 2025

Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025

View

February 24, 2025

DATE OF BOARD MEETING

View

February 5, 2025

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025

View

January 3, 2025

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024

View

December 6, 2024

POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON DECEMBER 6, 2024

View

December 2, 2024

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024

View

November 18, 2024

FORM OF PROXY FOR USE AT THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON DECEMBER 6, 2024

View

November 18, 2024

NOTICE OF EXTRAORDINARY GENERAL MEETING

View

November 18, 2024

(1)PROPOSED REVOCATION OF THE EXISTING GENERAL MANDATES AND GRANT OF THE NEW GENERAL MANDATES; AND (2) NOTICE OF EXTRAORDINARY GENERAL MEETING

View

November 15, 2024

PROPOSED REVOCATION OF EXISTING GENERAL MANDATES AND GRANT OF NEW GENERAL MANDATES

View

November 4, 2024

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024

View

October 4, 2024

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024

View

September 11, 2024

INTERIM REPORT 2024

View

September 5, 2024

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024

View

August 16, 2024

ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2024

View

August 6, 2024

DATE OF BOARD MEETING

View

August 6, 2024

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024

View

July 31, 2024

PROFIT WARNING

View

July 5, 2024

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024

View

June 6, 2024

(1)POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 6, 2024 (2) PAYMENT OF FINAL DIVIDEND AND (3) AMENDMENTS TO THE ARTICLES OF ASSOCIATION

View

June 6, 2024

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024

View

May 6, 2024

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

View

April 18, 2024

Notification Letter to Non-Registered Shareholders – Notice of Publication of 2023 Annual Report and Circular including Notice of Annual General Meeting and Environmental, Social and Governance Report 2023

View

April 18, 2024

Notification Letter to Registered Shareholders – Notice of Publication of 2023 Annual Report and Circular including Notice of Annual General Meeting, Proxy Form and Environmental, Social and Governance Report 2023

View

April 18, 2024

FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON JUNE 6, 2024

View

April 18, 2024

NOTICE OF ANNUAL GENERAL MEETING

View

April 18, 2024

(1) PROPOSED RE-ELECTION OF RETIRING DIRECTORS, (2) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES, (3) PROPOSED AMENDMENTS TO THE EXISTING ARTICLES OF ASSOCIATION AND ADOPTION OF NEW ARTICLES OF ASSOCIATION, (4) PROPOSED AMENDMENTS TO THE POST-IPO SHARE OPTION SCHEME, (5) RE-APPOINTMENT OF AUDITOR, (6) DECLARATION AND PAYMENT OF THE FINAL DIVIDEND OUT OF THE SHARE PREMIUM ACCOUNT AND (7) NOTICE OF ANNUAL GENERAL MEETING

View

April 18, 2024

ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2023

View

April 18, 2024

ANNUAL REPORT 2023

View

April 5, 2024

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

View

March 7, 2024

Final Dividend for the Year Ended December 31, 2023

View

March 7, 2024

ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023 AND CHANGE IN USE OF PROCEEDS

View

March 6, 2024

Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

View

March 6, 2024

(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

View

February 29, 2024

PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW ARTICLES OF ASSOCIATION

View

February 23, 2024

DATE OF BOARD MEETING

View

February 6, 2024

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

View

February 2, 2024

Notification Letter to Registered Shareholders – Mandatory Electronic Dissemination of Corporate Communications and Reply Form

View

February 2, 2024

Notification Letter to Non-Registered Shareholders – Mandatory Electronic Dissemination of Corporate Communications and Reply Form

View

January 30, 2024

POSITIVE PROFIT ALERT

View

January 5, 2024

(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

View

January 3, 2024

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

View

December 5, 2023

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

View

December 4, 2023

SUPPLEMENTAL ANNOUNCEMENT – DISCLOSEABLE TRANSACTION ACQUISITION OF 84% OF THE ISSUED SHARE CAPITAL OF THE TARGET COMPANY

View

November 27, 2023

ACQUISITION OF 84% OF THE ISSUED SHARE CAPITAL OF THE TARGET COMPANY

View

November 23, 2023

INSIDE INFORMATION ANNOUNCEMENT

View

November 6, 2023

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023

View

September 27, 2023

BUSINESS UPDATE IN RELATION TO THE UNITED STATES OF AMERICA

View

September 11, 2023

INTERIM REPORT 2023

View

September 7, 2023

List of Directors and Their Roles and Functions

View

September 7, 2023

Redesignation of Director

View

September 5, 2023

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023

View

August 17, 2023

ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2023

View

August 6, 2023

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023 (Revised)

View

August 6, 2023

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 June 2023

View

August 1, 2023

Date of Board Meeting

View

July 31, 2023

Positive Profit Alert

View

July 11, 2023

Grant of Share Options

View

July 6, 2023

Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023

View

June 2, 2023

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023

View

May 23, 2023

List of Directors and their Roles and Functions

View

May 23, 2023

Poll Results of The Annual General Meeting Held On May 23, 2023 and Appointment of Non-Executive Director

View

May 5, 2023

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023

View

April 18, 2023

Form of Proxy for Use at the Annual General Meeting to be Held on MAY 23, 2023

View

April 18, 2023

Notice of Annual General Meeting

View

April 18, 2023

(1) Proposed Election of New Directior and Proposed RE-Election of Retiring Directors, (2) Proposed Grant of General Mandates to Issue Shares and to Repurchase Shares (3) RE-Appointment of Auditor and (4) Notice of Annual General Meeting

View

April 18, 2023

Notification Letter to Shareholder – Notice of Publication of Environmental, Social and Governance Report 2022

View

April 18, 2023

Environmental, Social and Goverance Report 2022

View

April 18, 2023

Annual Report 2022

View

April 4, 2023

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023

View

March 28, 2023

Voluntary Announcement – Investment in and Construction of the Research and Development and Prouction Base for Vascular Interventional Medical Devices in Fuchun Bay New Town, Hangzhou

View

March 8, 2023

Terms of Reference of the Remuneration Committee

View

March 8, 2023

Announcement of Annual Results for the Year Ended December 31, 2022

View

March 6, 2023

Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023

View

February 23, 2023

Date of Board Meeting

View

February 2, 2023

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023

View

January 6, 2023

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022

View

December 22, 2022

Announcement of Offer Price and Allotment Results

View

December 22, 2022

Amended and Restated Memorandum and Articles of Association

View

December 22, 2022

Terms of Reference of the Audit Committee

View

December 22, 2022

Terms of Reference of the Remuneration Committee

View

December 22, 2022

Terms of Reference of the Nomination Committee

View

December 22, 2022

List of Directors and Their Roles and Functions

View

December 13, 2022

GLOBAL OFFERING

View

Corporate Headquarters

Units 303 & 305, 3/F Building 20E
Hong Kong Science Park
Shatin, N.T., Hong Kong, China
Tel: +852 2802 2288

EMEA Regional Headquarters

Drs. W. van Royenstraat 5
3871 AN Hoevelaken
The Netherlands

OrbusNeich

Careers
Disclaimer
Compliance
Privacy Statement
Customer Support
OrbusNeich Academy
Worldwide Locations
OrbusNeich P&F

OrbusNeich

© 2025 OrbusNeich Medical Group Holdings Limited or its affiliates. All rights reserved.

OrbusNeich, COMBO, eucaLIMUS, EZGuide, JADE, RESISTANT, Sapphire, Scoreflex, Scoreflex TRIO, SUPPORT C, Teleport, VITUS and Xtenza are trademarks of OrbusNeich Medical Group Holdings Limited or its affiliates.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT